Atsushi Ogata
7PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 25, 2021
Rapid attenuation of anti-SARS-CoV-2 antibodies in patients with musculoskeletal diseases in whom intensive immunosuppressive therapies were reinitiated after COVID-19: comment on the article by Curtis et al.Masashi Okamoto, Shoji Kawada, Hiroshi Shimagami
|Oct 22, 2020
Autoimmune myelofibrosis associated with systemic lupus erythematosus: a case report.Tansri Wibowo, Shoji Kawada, Yutaka Ishida
|May 16, 2019
Subcutaneous tocilizumab: recent advances for the treatment of rheumatoid arthritis.Atsushi Ogata, Yasuhiro Kato, Shinji Higa
|Nov 15, 2018
IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review.Atsushi Ogata, Yasuhiro Kato, Shinji Higa
|Oct 10, 2018
Long-term safety and efficacy of weekly subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis who had an inadequate response to subcutaneous tocilizumab every other week: Results from the open-label extension of the SHINOBI study.Atsushi Ogata, Yoshiya Tanaka, Tomonori Ishii
|Jun 17, 2017
A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: Results of the 12-week double-blind period.Atsushi Ogata, Yoshiya Tanaka, Tomonori Ishii
Pageof 2
